Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Accuray IncARAY-12.890.454.4439.63-34.38%-3.30%29.55$1.93$3.4924,344$2.02

Detail of Accuray Inc

 
CEO
Ms. Suzanne Winter M.B.A.
Employees
987
Industry
Medical Devices
Sector
Healthcare
Market cap
$200M

Company details

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$446.55M
Cost of goods (CoG)
-$303.63M
Gross profit (GP)
$142.92M
Operating expense (OE)
-$142.42M
Research and development (R&D)
-$49.73M
General and administrative (G&A)
-$92.68M
Operating income (OI)
$504,000.00
Other income expense (OIE)
-$700,000.00
Pretax income (PI)
-$11.82M
Tax (TAX)
-$3.72M
Net income (NI)
-$15.54M
Accuray Inc
ARAY • XNGS • US
$2.02
-0.72 (-26.18%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$0.16
Margin profit
-3.72%
52 week low
$1.41
52 week high
$3.01
50-day simple moving average
$1.93
200-day simple moving average
$1.93
Percent held by insiders
2.83%
Percent held by institutions
62.59%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
ARAY -23.68%
eps change
ARAY 0.00%